These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9019816)

  • 21. Fifth Conference on Retroviruses & Opportunistic Infections. Interview by Ron Baker.
    Follansbee S; Deeks S; Bartnoff H
    Newsline People AIDS Coalit N Y; 1998 Mar; ():7-14. PubMed ID: 11367453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiretroviral therapy: where are we?
    Hammer SM; Yeni P
    AIDS; 1998; 12 Suppl A():S181-8. PubMed ID: 9633001
    [No Abstract]   [Full Text] [Related]  

  • 23. AIDS deaths decline.
    Sullivan D; Sax PE
    AIDS Clin Care; 1997 Apr; 9(4):36, 33. PubMed ID: 11364218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The new age of HIV/AIDS. A special report on the XI International Conference on AIDS].
    Detres LL
    Sidahora; 1996; ():26-33. PubMed ID: 11364380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in HIV/AIDS therapy.
    Johnson SC; Gerber JG
    Adv Intern Med; 2000; 45():1-40. PubMed ID: 10635044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TB drugs interact adversely with protease inhibitors.
    AIDS Alert; 1996 Oct; 11(10):117-8. PubMed ID: 11363854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [HIV viral dynamic after antiretroviral treatment initiation: is a rapid decay a good pronostic?].
    Delaugerre C
    Pathol Biol (Paris); 2010 Dec; 58(6):403-5. PubMed ID: 19481371
    [No Abstract]   [Full Text] [Related]  

  • 28. Antiretroviral therapy in HIV/AIDS: update from San Francisco.
    Laurence J
    AIDS Read; 2000 Mar; 10(3):133-4. PubMed ID: 10758008
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effects of double and triple antiretroviral agents on the HCV viral load in patients coinfected with HIV and HCV].
    Gavazzi G; Richallet G; Morand P; Bouchard O; Bosseray A; Leclercq P; Micoud M
    Pathol Biol (Paris); 1998 Jun; 46(6):412-5. PubMed ID: 9769871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outing HIV (or, the tailor retailored).
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1996 Sep; 2(9):29-56. PubMed ID: 11363891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnosis of resistance in the treatment of AIDS: clarification of viral and cellular factors].
    Gröschel B; Spielhofen A; Stürmer M; Cinatl J; Doerr HW
    Dtsch Med Wochenschr; 2001 Nov; 126(44):1249-54. PubMed ID: 11687987
    [No Abstract]   [Full Text] [Related]  

  • 32. Selected highlights from the 5th Conference on Retroviruses and Opportunistic Infections.
    Bartnof HS
    BETA; 1998 Apr; ():49-56. PubMed ID: 11365269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [New era in AIDS therapy with highly active anti-retroviral agents].
    Maayan S
    Harefuah; 1998 Feb; 134(3):190-3. PubMed ID: 9662910
    [No Abstract]   [Full Text] [Related]  

  • 34. Therapy of early HIV infection: time for the pendulum to swing back?
    Schechter M; Harrison LH
    AIDS Clin Care; 1999 Oct; 11(10):79-81, 86. PubMed ID: 11366705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CROI--the 12th Conference on Retroviruses and Opportunistic Infections: a report on the conference.
    Willard S
    J Assoc Nurses AIDS Care; 2005; 16(2):53-4. PubMed ID: 16438127
    [No Abstract]   [Full Text] [Related]  

  • 36. Some relief from the epidemic.
    Cadman JA
    GMHC Treat Issues; 1997 Mar; 11(3):1-3. PubMed ID: 11364274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sustained disappearance of hepatitis C viremia in patients receiving protease inhibitor treatment for human immunodeficiency virus infection.
    Fialaire P; Payan C; Vitour D; Chennebault JM; Loison J; Pichard E; Lunel F
    J Infect Dis; 1999 Aug; 180(2):574-5. PubMed ID: 10395889
    [No Abstract]   [Full Text] [Related]  

  • 38. Visceral leishmaniasis in HIV-infected patients with non-detectable HIV-1 viral load after highly active antiretroviral therapy.
    Jiménez-Expósito MJ; Alonso-Villaverde C; Sardà P; Masana L
    AIDS; 1999 Jan; 13(1):152-3. PubMed ID: 10207569
    [No Abstract]   [Full Text] [Related]  

  • 39. A STEP summary of the XIth International AIDS Conference.
    Schouten JT
    STEP Perspect; 1996; 8(2):1-10. PubMed ID: 11364260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Open clinical trials for HIV/AIDS treatments.
    Townley D
    BETA; 1999 Apr; 12(2):53-6. PubMed ID: 11366699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.